Therapy of Nodal Follicular Lymphoma (Grade I/II) Clinical Stage I or II Using Involved Field Radiotherapy in Combination With Rituximab.
Phase of Trial: Phase II
Latest Information Update: 26 May 2014
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- Acronyms MIR
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database).
- 12 Jul 2011 EudraCT reports trial status is Recruiting, actual initiation date 13 Jun 2007, actual end date is 13 Oct 2011.
- 01 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.